TY  - GEN
AU  - Blumenschein,George
TI  - Sorafenib in lung cancer: clinical developments and future directions
SN  - 1556-1380
PY  - 2008///0922
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Benzenesulfonates
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Female
KW  - Follow-Up Studies
KW  - Forecasting
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Neoplasm Staging
KW  - Neovascularization, Pathologic
KW  - prevention & control
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Pyridines
KW  - Randomized Controlled Trials as Topic
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - antagonists & inhibitors
KW  - Risk Assessment
KW  - Sorafenib
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1097/JTO.0b013e318174e085
ER  -